Cogent Biosciences, Inc.

COGT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$98,165$53,229$139,886$219,684
Short-Term Investments$188,912$212,481$119,390$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$9,395$5,061$5,690$2,949
Total Curr. Assets$296,472$270,771$264,966$222,633
Property Plant & Equip (Net)$26,564$30,342$31,099$4,477
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$7,460$0$0
Tax Assets$0$0$0$0
Other NC Assets$4,862$4,864$4,745$4,982
Total NC Assets$31,426$42,666$35,844$9,459
Other Assets$0$0$0$0
Total Assets$327,898$313,437$300,810$232,092
Liabilities
Payables$12,013$10,655$5,842$3,483
Short-Term Debt$1,565$1,386$1,423$2,324
Tax Payable$0$0$0$0
Deferred Revenue$0$0$1,700$3,060
Other Curr. Liab.$42,132$26,127$17,884$8,210
Total Curr. Liab.$55,710$38,168$26,849$17,077
LT Debt$15,902$17,467$18,226$831
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$15,902$17,467$18,226$831
Other Liabilities$0$0$0$0
Cap. Leases$17,467$18,853$19,649$3,155
Total Liabilities$71,612$55,635$45,075$17,908
Equity
Pref Stock$110,600$60,035$65,830$85,400
Common Stock$110$86$70$44
Retained Earnings-$859,483-$603,624-$411,214-$270,973
AOCI$447$246-$104$0
Other Equity$1,004,612$801,059$601,153$399,713
Total Equity$256,286$257,802$255,735$214,184
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$327,898$313,437$300,810$232,092
Net Debt-$80,698-$34,376-$120,237-$216,529